Article
A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin–MLL Inhibition
20 Oct 2022
Abstract excerpt
Menin interacts with oncogenic MLL1-fusion proteins, and small molecules that disrupt these associations are in clinical trials for leukemia treatment. By integrating chromatin-focused and genome-wide CRISPR screens with genetic, pharmacologic, and biochemical approaches, we discovered a conserved molecular switch between the MLL1-Menin and MLL3/4-UTX chromatin-modifying complexes that dictates response to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
